Login / Signup
The minority population was 38% of the total U.S. population in 2014 and is expected to rise to 56% by 2060. Although minorities make up…
Don’t Confuse the Art and Science of Medicine: PCI vs CABG for Left Main Disease
(Updated on August 20 with a response from Bernard Gersh.) It is often said that medicine is both an art and a science. In an…
Left Main Coronary Disease Trials: Far from ‘Close to Consensus’
(Updated with a response from Bernard Gersh on August 18) In a recent CVCTCardioBrief blog, Dr. Gersh questioned whether the recent controversy around the…
Left Main Coronary Disease Trials: Close to Consensus
In 1976, the Veteran’s Administration trial of 113 patients comparing coronary bypass surgery (CABG) with medical therapy ushered in the era of revascularization for left…
Reflections on Virtual Meetings During the COVID-19 Pandemic
I started my cardiology fellowship in 1963 at the Johns Hopkins University school of medicine after time in the laboratory of Dr. Donald Gregg at…
How to increase inclusivity in clinical trials: a patient’s perspective
For many years most clinical trials were done on white men only. African Americans, women, and other minorities were not included. It is reported that…
Learning Amidst A Pandemic: Collecting COVID-19 Data Across Cardiovascular Clinical Trials
In December 2019, the rumblings of a virus meandering its way through Wuhan province in China slowly made their way to Western airways. Little attention…